Poniard Pharmaceuticals
PARD · OTC
$0.0001+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.
Key indicators
PARD profitability and balance sheet ratios
EPS -$2.52 in Sep 2011, against -$5.35 a year earlier.
| Period | EPS |
|---|---|
| Dec 2009 | -$14.32 |
| Mar 2010 | -$11.01 |
| Jun 2010 | -$5.50 |
| Sep 2010 | -$5.35 |
| Dec 2010 | -$4.27 |
| Mar 2011 | -$2.40 |
| Jun 2011 | -$2.59 |
| Sep 2011 | -$2.52 |
Income statement
No financial statements are reported for Poniard Pharmaceuticals.
Balance sheet
What the company owns and owes at period end
Total assets
Total liabilities
| Line item | Mar 2011 | Jun 2011 | Sep 2011 |
|---|---|---|---|
| Total assets | $12.2M | $10.0M | $7.7M |
| Total liabilities | $2.9M | $3.7M | $4.6M |
| Shareholder equity | $9.3M | $6.3M | $3.1M |
| Cash and short-term investments | $5.5M | $3.7M | $2.0M |
| Total debt | $1.6M | $1.6M | $1.6M |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.